MedTrace Logo

Effect of Probiotics on Eradication of Persistent H.Pylori Infection

NCT05674864 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2023-01-09

No results posted yet for this study

Summary

This study aims to investigate the possible safety and efficacy of probiotics (Bifidobacterium Infants, Enterococcus Feacium, and Lactobacillus Acidophilus) on the eradication rate of Helicobacter pylori and the incidence of adverse effects (AEs) of the concurrent rescue regimen in a patient with persistent H. Pylori infection.

Conditions

  • Persistent Helicobacter Pylori Infection

Interventions

DRUG

Bifidobacterium Infants plus Enterococcus Feacium plus Lactobacillus Acidophilus

Bifidobacterium Infants, Enterococcus Feacium, and Lactobacillus Acidophilus combination will be given as one capsule three times daily for 14 days

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Noura Elsaka · Tanta University

  • Mohamed Abd El-Moaty, Professor · Zagazig University

  • Sahar Hegazy, Professor · Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-08-01
Completion
2023-09-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05674864 on ClinicalTrials.gov